ストックスクリーナーアプリを入手
107.85
0.42%
0.455
アフターアワーズ：
107.85
前日終値:
$107.39
開ける：
$104.32
24時間の取引高:
311.18K
Relative Volume:
1.69
時価総額：
$2.45B
収益：
$240.87M
当期純損益:
$53.34M
株価収益率:
46.41
EPS:
2.3238
ネットキャッシュフロー:
$66.23M
1週間 パフォーマンス:
+18.84%
1か月 パフォーマンス:
+23.24%
6か月 パフォーマンス:
+14.05%
1年 パフォーマンス:
+17.02%
1日の値動き範囲:
$102.91
$108.12
1週間の範囲:
$88.34
$115.33
52週間の値動き範囲:
$71.42
$115.33
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Compare LMAT vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
107.85 | 2.44B | 240.87M | 53.34M | 66.23M | 2.3238 |
|
ISRG
Intuitive Surgical Inc
|
497.42 | 176.23B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
174.21 | 50.22B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.08 | 41.28B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.28 | 37.50B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.39 | 37.20B | 27.43B | 1.27B | 1.01B | 1.5829 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-06 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 開始されました | Wells Fargo | Equal Weight |
| 2024-10-15 | 開始されました | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 再開されました | Lake Street | Buy |
| 2024-05-31 | 再開されました | ROTH MKM | Buy |
| 2024-04-26 | アップグレード | Stifel | Hold → Buy |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-06 | 開始されました | Oppenheimer | Outperform |
| 2023-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2023-05-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 開始されました | Jefferies | Buy |
| 2021-02-12 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | アップグレード | Sidoti | Neutral → Buy |
| 2019-10-24 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | アップグレード | Lake Street | Hold → Buy |
| 2019-10-14 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 繰り返されました | Barrington Research | Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | アップグレード | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 再開されました | ROTH Capital | Buy |
| 2018-04-26 | ダウングレード | Stifel | Buy → Hold |
| 2018-04-26 | アップグレード | The Benchmark Company | Hold → Buy |
| 2017-10-27 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2017-07-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 開始されました | First Analysis Sec | Overweight |
| 2017-02-22 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-07-28 | 繰り返されました | Barrington Research | Outperform |
| 2016-02-25 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Lemaitre Vascular Inc (LMAT) 最新ニュース
Roth Mkm Reaffirms Buy Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views - Benzinga
LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results - marketscreener.com
LeMaitre (LMAT) Stock Trades Up, Here Is Why - Finviz
LMAT Price Target Raised by Wells Fargo | LMAT Stock News - GuruFocus
Wells Fargo & Company Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LMAT: Citizens Raises Price Target to $118, Maintains Market Out - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings - MarketBeat
Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating - marketscreener.com
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
LeMaitre Vascular stock reaches 52-week high at 103.05 USD - Investing.com
Income Plays: Is LeMaitre Vascular Inc stock a value trapJuly 2025 Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LEMAITRE VASCULAR INC SEC 10-K Report - TradingView
LeMaitre Vascular (LMAT) Reports Strong Q4 2025 Performance and Positive 2026 Outlook - GuruFocus
LeMaitre Vascular Q4 Earnings Call Highlights - MarketBeat
Insider Sell: Does LeMaitre Vascular Inc. stock have upside surprise potential - mfd.ru
Discipline and Rules-Based Execution in LMAT Response - Stock Traders Daily
LeMaitre Vascular (NASDAQ:LMAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Earnings call transcript: LeMaitre Vascular beats Q4 2025 expectations By Investing.com - Investing.com India
LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - Finviz
LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Releases FY 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular beat Q4 sales expectations, raises dividend - TradingView
(LMAT) LeMaitre Vascular, Inc. Expects Q1 Revenue Range $65.6M$67.6M - marketscreener.com
LeMaitre lifts dividend 25% and okays $100M stock buyback - Stock Titan
LeMaitre Vascular earnings on deck: Can margin gains continue? - Investing.com
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Exploring LeMaitre Vascular's Earnings Expectations - Benzinga
Lemaitre Vascular Inc (LMAT) Tops Q4 2025 Earnings Estimates — EPS $0.75 vs $0.56 Expected - AlphaStreet News
Lemaitre Vascular Inc (LMAT) Reports Q4 2025 Earnings — EPS $0.75 - AlphaStreet News
LeMaitre (LMAT) To Report Earnings Tomorrow: Here Is What To Expect - Finviz
Is LeMaitre Vascular Inc a strong candidate for buy and holdJuly 2025 Fed Impact & Stock Market Timing Techniques - baoquankhu1.vn
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Buy at Wall Street Zen - MarketBeat
LeMaitre Vascular (LMAT) Analyst Ratings Maintain 'Outperform' w - GuruFocus
Barrington Research Reaffirms "Outperform" Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular stock rating maintained at outperform by Citizens - Investing.com Canada
LeMaitre Vascular (LMAT) Expected to Announce Earnings on Wednesday - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Purchased by Public Sector Pension Investment Board - Defense World
Will LeMaitre Vascular Inc. (LHU) stock beat international competitionMarket Movers & Entry Point Confirmation Signals - mfd.ru
Behavioral Patterns of LMAT and Institutional Flows - Stock Traders Daily
LeMaitre Vascular, Inc. $LMAT Shares Sold by Envestnet Asset Management Inc. - MarketBeat
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 - GlobeNewswire
Sentiment Recap: Is LeMaitre Vascular Inc stock showing strong momentum - baoquankhu1.vn
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Potential 19.79% Upside and Robust Growth in the Healthcare Sector - DirectorsTalk Interviews
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expensive For A Reason? A Look At Its Intrinsic Value - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Ranger Investment Management L.P. Lowers Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
3 Small-Cap Stocks We Keep Off Our Radar - Finviz
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 20% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
(LMAT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Lemaitre Vascular Inc (LMAT) 財務データ
収益
当期純利益
現金流量
EPS
3.00%
0.01%
大文字化:
|
ボリューム (24 時間):